Metabolic Effects of the Biguanides and Possible Mechanism of Action
- 1 February 1968
- journal article
- research article
- Published by American Diabetes Association in Diabetes
- Vol. 17 (2) , 96-104
- https://doi.org/10.2337/diab.17.2.96
Abstract
The relationship between the biguanide inhibition of oxidations and their effect on glucose metabolism in vitro was investigated. A good correlation between the concentration of biguanide causing a half-maximal inhibition of pyruvate oxidation (Ki) and the concentration eliciting a half-maximal stimulation (Ks) of glucose uptake in several tissues from rat, guinea pig and pigeon. Guinea pig epididymal fat pad was the most sensitive tissue tested. Gluconeogenesis by minced guinea pig liver was inhibited by the biguan ides. The ability of the biguanides to inhibit gluconeogenesis correlated well with their ability to inhibit pyruvate oxidation. Inhibition of oxidations by the biguanides does not appear to be a result of a direct inhibition of the enzymes catalyzing these oxidations but seems to be secondary to a primary effect on the coupled processes of electron transport and oxidative phosphorylation. Objections to the theory that the metabolic actions of the biguanides are a result of their inhibition of oxidative processes are discussed. The inhibition of oxidations caused by the biguanides is directly related to their metabolic and hypoglycemic effects.This publication has 5 references indexed in Scilit:
- The effect of phenformin hydrochloride on serum cholesterol and triglyceride levels of the stable adult diabeticMetabolism, 1966
- Site-specific uncoupling and inhibition of energy transfer by biguanidesBiochimica et Biophysica Acta (BBA) - General Subjects, 1964
- The present state of knowledge on the mode of action of the antidiabetic diguanidesMetabolism, 1964
- A Study of the Action of Hypoglycemia-producing Biguanide and Sulfonylurea Compounds on Oxidative PhosphorylationJournal of Biological Chemistry, 1962
- CLINICAL EVALUATION OF FORMAMIDINYLIMINOUREA, A NEW BIGUANIDE ORAL BLOOD SUGAR LOWERING COMPOUND: COMPARISON WITH OTHER HYPOGLYCEMIC AGENTSAnnals of Internal Medicine, 1959